ANIMATION

Vasopressin V2-Receptor Blockage

Share this animation:

Hyponatremia is a condition characterized by low sodium concentration in blood serum. This may be caused by overactivity of anti-diuretic hormone, which results in increased reabsorption of water from the collecting duct. Tolvaptan is an FDA-approved antagonist of the vasopressin V2-receptor. Inhibition of this receptor prevents the expression of aquaporin channels along the collecting duct, promoting diuresis and correcting sodium levels in serum.

Share It:
Contact XVIVO

Client


Otsuka

We were very pleased with the final product, the speed at which you team completed the rounds from story board to rough animation/final animation, and the flexibility to change parts of the animation when our client came in with additional changes at the last hour. Our client was also very happy with the final product. In addition, Mike and Roz were very buttoned up with the communication flow, and always available when we needed to discuss changes. It would be my pleasure to provide a recommendation if needed.

Dr. Chris. Tobias, OmniGuide Project, Dudnyk
Share this animation: